Tag: Venova Medical
Early feasibility study for Velocity pAVF system now fully enrolled
Venova Medical has announced the completion of patient enrolment in the company's VENOS-2 early feasibility study of the Velocity percutaneous arteriovenous fistula (pAVF) system...
VENOS-1 FIH trial one-year results demonstrate advantages of the next-generation Velocity...
This morning, at the Controversies in Dialysis Access (CiDA) 2024 meeting (3–5 October, Washington D.C., USA), Robert Shahverdyan (Hamburg, Germany) gave a presentation sharing...